|
Volumn 315, Issue 7113, 1997, Pages 953-
|
The future of healthcare systems. Method for rigorously assessing cost effectiveness of new drugs must be set up.
a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COST BENEFIT ANALYSIS;
DRUG COST;
FORECASTING;
HEALTH CARE DELIVERY;
HUMAN;
NATIONAL HEALTH SERVICE;
NOTE;
UNITED KINGDOM;
COST-BENEFIT ANALYSIS;
DELIVERY OF HEALTH CARE;
DRUG COSTS;
FORECASTING;
GREAT BRITAIN;
HUMANS;
STATE MEDICINE;
|
EID: 0031565036
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (4)
|
References (0)
|